First Horizon Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Buy |
8,315
+1,128
| +16% | +$114K | 0.02% | 270 |
|
|
2025
Q1 | $725K | Sell |
7,187
-282
| -4% | -$28.4K | 0.02% | 281 |
|
|
2024
Q4 | $667K | Buy |
7,469
+1,044
| +16% | +$91.9K | 0.02% | 291 |
|
|
2024
Q3 | $538K | Buy |
6,425
+41
| +0.6% | +$3.23K | 0.02% | 337 |
|
|
2024
Q2 | $492K | Buy |
6,384
+248
| +4% | +$18.2K | 0.01% | 335 |
|
|
2024
Q1 | $420K | Buy |
6,136
+1,166
| +23% | +$75K | 0.01% | 360 |
|
|
2023
Q4 | $287K | Buy |
4,970
+356
| +8% | +$19K | 0.01% | 413 |
|
|
2023
Q3 | $244K | Buy |
4,614
+153
| +3% | +$8.02K | 0.01% | 424 |
|
|
2023
Q2 | $241K | Buy |
4,461
+258
| +6% | +$13.5K | 0.01% | 440 |
|
|
2023
Q1 | $210K | Sell |
4,203
-537
| -11% | -$25.3K | 0.01% | 457 |
|
|
2022
Q4 | $219K | Buy |
4,740
+121
| +3% | +$5.24K | 0.01% | 436 |
|
|
2022
Q3 | $178K | Buy |
4,619
+452
| +11% | +$18.1K | 0.01% | 465 |
|
|
2022
Q2 | $154K | Buy |
4,167
+462
| +12% | +$18.8K | 0.01% | 524 |
|
|
2022
Q1 | $164K | Buy |
3,705
+516
| +16% | +$22.4K | 0.01% | 410 |
|
|
2021
Q4 | $135K | Sell |
3,189
-15
| -0.5% | -$630 | ﹤0.01% | 595 |
|
|
2021
Q3 | $138K | Buy |
3,204
+605
| +23% | +$26.8K | ﹤0.01% | 586 |
|
|
2021
Q2 | $111K | Sell |
2,599
-80
| -3% | -$3.37K | 0.01% | 520 |
|
|
2021
Q1 | $103K | Buy |
2,679
+207
| +8% | +$7.83K | 0.01% | 500 |
|
|
2020
Q4 | $89K | Sell |
2,472
-525
| -18% | -$18.9K | 0.01% | 451 |
|
|
2020
Q3 | $114K | Buy |
2,997
+251
| +9% | +$9.67K | 0.01% | 379 |
|
|
2020
Q2 | $95K | Sell |
2,746
-205
| -7% | -$7.38K | 0.01% | 397 |
|
|
2020
Q1 | $95K | Buy |
2,951
+499
| +20% | +$19.5K | 0.01% | 378 |
|
|
2019
Q4 | $111K | Buy |
2,452
+652
| +36% | +$27.3K | 0.01% | 408 |
|
|
2019
Q3 | $73K | Hold |
1,800
| – | – | 0.01% | 468 |
|
|
2019
Q2 | $77K | Hold |
1,800
| – | – | 0.01% | 479 |
|
|
2019
Q1 | $69K | Hold |
1,800
| – | – | 0.01% | 468 |
|
|
2018
Q4 | $64K | Hold |
1,800
| – | – | 0.01% | 476 |
|
|
2018
Q3 | $69K | Hold |
1,800
| – | – | 0.01% | 515 |
|
|
2018
Q2 | $59K | Buy |
+1,800
| New | +$54.3K | ﹤0.01% | 541 |
|
|
2016
Q1 | – | Sell |
-260
| Closed | -$5K | – | 1329 |
|
|
2015
Q4 | $5K | Hold |
260
| – | – | ﹤0.01% | 1035 |
|
|
2015
Q3 | $4K | Hold |
260
| – | – | ﹤0.01% | 1212 |
|
|
2015
Q2 | $5K | Hold |
260
| – | – | ﹤0.01% | 1192 |
|
|
2015
Q1 | $5K | Buy |
260
+20
| +8% | +$316 | ﹤0.01% | 1220 |
|
|
2014
Q4 | $3K | Buy |
240
+25
| +12% | +$320 | ﹤0.01% | 1302 |
|
|
2014
Q3 | $3K | Sell |
215
-299
| -58% | -$3.77K | ﹤0.01% | 1324 |
|
|
2014
Q2 | $6K | Sell |
514
-39
| -7% | -$507 | ﹤0.01% | 1172 |
|
|
2014
Q1 | $7K | Hold |
553
| – | – | ﹤0.01% | 1043 |
|
|
2013
Q4 | $7K | Hold |
553
| – | – | ﹤0.01% | 1019 |
|
|
2013
Q3 | $6K | Buy |
+553
| New | +$5.98K | ﹤0.01% | 920 |
|
Other funds holding BSX
First Horizon Advisors's BSX Position: Q2 2025 in Review
First Horizon Advisors increased its Boston Scientific (BSX) stake by 16% in Q2 2025, buying an estimated $114K and bringing the position to 8,315 shares worth $893K. The position accounts for 0.02% of the portfolio, ranked #270.
First Horizon Advisors first reported a position in BSX in Q3 2013 and has held it in 39 quarters since. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- First Horizon Advisors held 8,315 shares of Boston Scientific worth $893K as of Q2 2025.
- First Horizon Advisors bought 1,128 Boston Scientific shares in Q2 2025, an estimated $114K.
- Boston Scientific made up 0.02% of First Horizon Advisors's portfolio in Q2 2025, its #270 holding.
- First Horizon Advisors first reported a position in Boston Scientific in Q3 2013 and has held it in 39 quarters since.
- 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.